24СʱÈÈÃÅ°æ¿éÅÅÐаñ    

¡¾µ÷¼Á¡¿±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2024Äê16¸öרҵ½ÓÊܵ÷¼Á
²é¿´: 4194  |  »Ø¸´: 12
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷ÕßWORKDAY½«ÔùËÍÄú 5 ¸ö½ð±Ò
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

WORKDAY

гæ (³õÈëÎÄ̳)

[ÇóÖú] Éó¸åÈËÒâ¼ûmajor revision£¬¸ÄºóÖØͶ±¯¾ç£¬ÈçºÎÉêËߣ¿ÒÑÓÐ7È˲ÎÓë

¸÷λͬÁÅ£¬ÔÚͶ¸åBMC nephrology Ö®ºóÁ½Î»Éó¸åÈ˸øµÄÒâ¼û¶¼ÊÇmajor revision£¬ºóÔð±à»ØÐÅrejectµ«ÊÇÌá³ö£ºÈç¹û¿ÉÒÔpoint by point»Ø¸´Éó¸åÒâ¼û£¬»¶Ó­ÎÒÃÇresubmit a new manuscript£¬°´ÕÕÔð±àµÄÒªÇóÒ»Ò»Ð޸ĺóresubmit£¬¿ÉÊÇÒ»¸öÔºóÔð±à»ØОܵôÁË£¬Ò²Ã»ËÍÉó¡£ÎÒÀÕ¸öÈ¥£¬ÕâÖÖÇé¿öÓо­ÑéµÄͬ־ָµ¼Ò»Ï£¬ÎÒÊǸÃÉêËßÄØ»¹ÊǸÃÉêËßÄØ£¿Ôð±àΪɶûËÍÉóÖ±½Ó¾ÜµôÁË£¿Ï¸½ÐżþÄÚÈÝ£º
µÚÒ»´ÎÔð±à»ØÐŵÄÄÚÈÝ£ºPeer review of your manuscript is now complete and, based on the reports, I am sorry to say that we cannot consider the manuscript for publication at this time.

We think it may be possible to revise your manuscript to address these comments but that this would require longer than our standard revision period. However, we are willing to consider your manuscript further once all the concerns have been addressed. Therefore, if you are able to address all of these concerns, please do submit a new manuscript to BMC Nephrology. If you are able to do this, a full covering letter, explaining the revisions made, should accompany the submission.

Their reports, together with any other comments, are below. Please also take a moment to check our website at https://www.editorialmanager.com/bnep/ for any additional comments that were saved as attachments. Please note that as BMC Nephrology has a policy of open peer review, you will be able to see the names of the reviewers.

If you can address all of these concerns raised, please do submit a new manuscript to https://www.editorialmanager.com/bnep/.

We request that a point-by-point response letter accompanies your revised manuscript. This letter must provide a detailed response to each reviewer/editorial point raised, describing what amendments have been made to the manuscript text and where these can be found (e.g. Methods section, line 12, page 5). Please also ensure that all changes to the manuscript are indicated in the text by highlighting or using track changes. If you disagree with any comments raised, please provide a detailed rebuttal to help explain and justify your decision.
Please note that this decision applies across the BMC-series journals (http://www.biomedcentral.com/authors/bmcseries#journallist). Therefore, if you were to submit your revised manuscript to another journal within the BMC series, your submission should also be accompanied by a full covering letter.

I wish you every success with your research and hope that you will consider us again in the f

µÚ¶þ´ÎÔð±à»ØÐÅÄÚÈÝ£º
Editor\'s comments:
The paper is useful but not of practical assistance. A sudden progression of renal dysfunction in patients with CKD already on a nephrotoxic chronic medication will always require a search for any reversible etiology.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

WORKDAY

гæ (³õÈëÎÄ̳)

Ëͺ컨һ¶ä
ÒýÓûØÌû:
4Â¥: Originally posted by bobvan at 2019-12-12 02:20:02
¹À¼Æ±à¼­¶ÔÄãµÄ¸Ä¶¯²»ÂúÒâ¡£¿ÉÒÔ»»¸öÆÚ¿¯Í¶¡£

лл

·¢×ÔСľ³æIOS¿Í»§¶Ë
6Â¥2019-12-12 12:24:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 13 ¸ö»Ø´ð

zhangjiangbo

ľ³æ (ÕýʽдÊÖ)

ÖØÐÂÉÏ´«£¬ÕâÖÖÇé¿ö´ó²¿·ÖÊÇ¿Ó£¬×îºÃÖ±½Ó¸ÄͶ

·¢×ÔСľ³æAndroid¿Í»§¶Ë
2Â¥2019-12-11 22:20:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liuze2125051

ľ³æ (ÖøÃûдÊÖ)

3Â¥2019-12-11 23:07:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bobvan

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
paperhunter: ½ð±Ò+1, ¹ÄÀø½»Á÷ 2019-12-12 22:02:14
¹À¼Æ±à¼­¶ÔÄãµÄ¸Ä¶¯²»ÂúÒâ¡£¿ÉÒÔ»»¸öÆÚ¿¯Í¶¡£

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

4Â¥2019-12-12 02:20:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á +3 Õæ³ÏÇÒÖËÈÈ 2024-03-29 3/150 2024-03-29 19:58 by siliushui
[¿¼ÑÐ] 305Çóµ÷¼Á +3 ·É·ÉÒ»¸ö·É 2024-03-29 3/150 2024-03-29 19:33 by XD789
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤ 085602 »¯Ñ§¹¤³Ì 312·Ö Çó¸öµ÷¼Á»ú»á +16 liu85623724 2024-03-24 17/850 2024-03-29 16:53 by ³ÔÄÔ×ӵijæ×Ó
[˶²©¼ÒÔ°] Ò»Ö¾Ô¸³¤°²´óѧ£¬²ÄÁÏÓ뻯¹¤×¨Ë¶301 +3 ÏÉŮСºöÓÆ 2024-03-25 3/150 2024-03-29 15:16 by shiyihelulu
[¿¼ÑÐ] 318»¯¹¤Çóµ÷¼Á +5 ÃÛÌDz»ÌðZ 2024-03-28 5/250 2024-03-29 15:12 by SDUT365
[¿¼ÑÐ] »¯Ñ§¹¤³Ìר˶Çóµ÷¼Á +6 yichangÎÄ 2024-03-29 6/300 2024-03-29 14:03 by ·Ç褾ÍÊÇÎÒ
[¿¼ÑÐ] 284Çóµ÷¼Á +3 ÁÖÖÓÁù 2024-03-27 6/300 2024-03-29 11:47 by ÁÖÖÓÁù
[¿¼ÑÐ] 312Çóµ÷¼Á +3 hffg. 2024-03-27 6/300 2024-03-29 09:37 by fenggou82
[¿¼ÑÐ] Ë«Ò»Á÷¸ßУÄÏÁÖ£¬»¯Ñ§/»¯¹¤/²ÄÁÏ µ÷¼ÁÁªÏµ +12 wang333666 2024-03-24 17/850 2024-03-29 01:40 by °®¿ÞµÄÊÝÈõ¼¦×¦
[¿¼ÑÐ] 302Çóµ÷¼Á +3 ¡ª*¡ª 2024-03-27 3/150 2024-03-28 22:51 by ms629
[¿¼ÑÐ] ¿¼ÑÐ304»¯¹¤Çóµ÷¼Á +8 abc123456* 2024-03-27 10/500 2024-03-28 21:59 by qlm5820
[¿¼ÑÐ] ±¾¿ÆÌ«Ô­Àí¹¤´óѧ£¬300·ÖÇóµ÷¼Á +5 ²Ø´ºÉ½ 2024-03-27 5/250 2024-03-28 16:12 by shiyihelulu
[¿¼ÑÐ] 317Çóµ÷¼Á ±¾¿ÆÐÂÄÜÔ´²ÄÁÏÓëÆ÷¼þ£¨µç»¯Ñ§£© +3 É곯Ðñ 2024-03-24 3/150 2024-03-28 14:49 by renwenfeng
[¿¼ÑÐ] 301Çóµ÷¼Á +6 СӨ@ 2024-03-28 6/300 2024-03-28 11:21 by Áúɽ110
[¿¼ÑÐ] 320»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á +8 Wjrjxmt 2024-03-27 8/400 2024-03-28 10:46 by Ëæ·ç¶ø¶¯ß×
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤ ר˶310ÇóÇóÏëÓÐѧÉÏ +12 ÏëÉÏѧ°¡°¡°¡°¡° 2024-03-23 12/600 2024-03-28 07:09 by EBSD
[¿¼ÑÐ] 307Çóµ÷¼Á +5 Ôç²ÍÍí²Í 2024-03-27 6/300 2024-03-27 23:02 by ÐÇ¿ÕÐÇÔÂ
[ÂÛÎÄͶ¸å] ÓÐÈËͶ¹ýEnergyÆÚ¿¯Ã´£¿µ¼Ê¦ÊÇIEEE Fellow£¬»á²»»áÏñ±ðµÄIEEEÆÚ¿¯Ò»ÑùÓеãÕչˣ¿ 50+4 huanpo116 2024-03-26 4/200 2024-03-27 11:16 by ÏþÄ¿³ç
[¿¼ÑÐ] 294Çóµ÷¼Á +7 Ó­Çï87 2024-03-23 8/400 2024-03-26 11:29 by 201531180024
[¿¼ÑÐ] 313Çóµ÷¼Á +5 Ò»Õ½ÉÏ°¶Õß 2024-03-23 5/250 2024-03-26 10:41 by »·¾³¹¦ÄܲÄÁÏ-QU
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û